BestBitcoinMining.com

Zacks Investment Research Lowers Avadel Pharmaceuticals (NASDAQ:AVDL) to Sell

Zacks Investment Research Lowers Avadel Pharmaceuticals (NASDAQ:AVDL) to Sell

Zacks Investment Research cut shares of Avadel Pharmaceuticals (NASDAQ:AVDL) from a hold rating to a sell rating in a research note released on Friday morning, Zacks.com reports. According to Zacks, “Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM).




BestBitcoinMining.com